HybioPeptide innovation · Since 1998
From intelligent molecular design to globally compliant manufacturing, Hybio advances peptide and oligonucleotide therapies across the full development journey.
Company Profile
Founded in 1998, Hybio Pharmaceutical is dedicated to decoding the molecular potential of peptides and oligonucleotides. We combine AI-enabled drug discovery with an integrated industrial platform spanning research, APIs, finished dosage forms, and global commercialization.
From intelligent peptide sequence design to the first-generic approval by the U.S. FDA, our innovation now supports healthcare systems across more than 90 countries and regions.
About Hybio0
Years Experience
Dedicated to peptide innovation since 1998
0+
Global Markets
Formulations serving countries and regions worldwide
0+
Employees
Science, quality, manufacturing, and commercial talent
Products
01 / FDFPrecision formulations
A multi-dosage-form technology platform translating peptide science into reliable, globally accessible therapies.
02 / APIPurity at commercial scale
High-purity peptide active ingredients powered by proprietary synthesis, purification, and scale-up technologies.
03 / CRDMOOne integrated partner
End-to-end research, development, clinical, manufacturing, and commercialization support for complex peptide programs.
Company Platform
Hybio connects proprietary peptide technologies, formulation science, global regulatory quality, and industrial-scale production in one integrated platform.
Explore the platform
01
AI-assisted target insight and translational research reveal high-value therapeutic opportunities.
02
Sequence engineering and multi-target drug design optimize potency, selectivity, and developability.
03
Proprietary synthesis, purification, and impurity-control technologies move candidates toward scale.
04
Formulation, analytical, and regulatory capabilities support global development and clinical supply.
05
Vertically integrated cGMP production carries APIs and finished products into commercial markets.
Global Footprint
Our integrated quality system connects research and production bases in China with partners, regulators, and healthcare markets across the Americas, Europe, and Asia-Pacific.
USA
Europe
China
Asia
20+
API markets
90+
FDF markets
Global
Quality standards
Latest News
